Shigeto Ikeda, A Revolutionary in Pulmonary Medicine — in Memoriam

Interim Results from the RIDTELC Lung Study

Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and pre-malignant lesions: association with clinical characteristics

Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis

Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer

History of Bronchoscopy

Bronchoscopic treatment of early cancer

Honor Lectures

Summary of late breaking news section

Newsletter enters seventh year

National Lung Health Education Program/Association of Respiratory Alliance

New lung cancer screening trial approval by the National Cancer Institute

Early lung cancer action project

Can semi-automated image cytometry on induced sputum become a screening tool for lung cancer?

Lung cancer in patients with idiopathic pulmonary fibrosis

An evaluation of screening for lung cancer in Niigata Prefecture, Japan: A population-based case study

Role of p53 as a prognostic factor for survival in lung cancer: A systematic review of the literature with a meta-analysis

Expression of vascular growth factor (VEFG) in non-small cell lung cancer (NSCLC): Association with p53 gene mutation and prognosis

Prognostic molecular markers in non-small cell lung cancer

Proposed biliogical staging for lung cancer. A biological staging model for operable non-small cell lung cancer

Angiogenesis inhibitors in the staging and treatment of lung cancer

Lung Cancer Frontiers Editorial Board news

Enlarging the debate on lung cancer screening

Highlights of the 2nd International Lung Cancer Molecular Biomarkers

Workshop: A European strategy for developing lung cancer molecular diagnosis in high-risk populations

Early lung cancer action project: findings on baseline and annual repeat screening CT and future projects

Aberrant methylation of genes in the pathogenesis of lung cancer

Highlights of the International Association for the study of lung cancer (IASLC) 3rd International conference on Prevention and Early Detection of Lung Cancer

The possibility of clinical application of malignancy associated with changes (MAC) for early detection of lung cancer

Bronchoscopic treatment (BT) of medically inoperable patients with radiographically occult lung cancer: a follow-up study

Approaches to population based screening

PET scan can detect radiologically "occult" lung cancer in the central airway

Clinical usefulness of hnRNP B1 protein for detection of early lung cancer

Lung cancer incidence and selenium supplementation. An update of a clinical trial 

Predicting lung cancer by detecting aberrant promoter methylation in sputum

sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR

Fluorescence bronchoscopy in the detection of pre-invasive bronchial lesions in patients with sputum cytology suspicious or positive for malignancy

Survival after resection of metachronous non-small cell lung cancer in 127 patients

The influence of hospital volume on survival after resection for lung cancer

Lung cancer in patients under 50 years old

Five-year survival and later outcome of patients with x-ray occult lung cancer detected by sputum cytology

Historical vignette on mesotheliomas

Outcome of bronchial carcinoma in-situ

Recent studies of lung cancer biomarkers

The multidisciplinary approach to lung cancer

Correlation of tumor size and survival in patients with stage 1A non-small cell lung cancer

Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time

Induction chemotherapy before surgery for early-stage lung cancer: a novel approach

Synchronous roentgenographically occult lung cancer in patients with resectable primary lung cancer

Advances in sputum analysis for screening and early detection of lung cancer

National Health Lung Education Program spirometry statement published

Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer

Observer variability in histopathological reporting of bronchial biopsy specimens

How golden is the gold standard? The elusive pathology of early lung cancer

A multi-center trial with a somatostatin analog 99mTC depreotide in the evaluation of solitary pulmonary nodules

First successful pneumonectomy for lung cancer performed in 1933

Second international conference on COPD held in Birmingham, UK, June 14-17, 2000

Prospects for lung cancer screening

Early hilar lung cancer

Bronchoscopy for peripheral lung cancer

Lung cancer statistics

Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer

Racial differences in the treatment of early-stage lung cancer

Emphysematous lesions and lung function in healthy smokers 60 years of age

Geno Saccomanno, MD, PhD

Lung cancer identification based on molecular markers

Current status of fluorescence bronchoscopy and the future of optics in localization and intervention of early lung cancer

Early lung cancer action project

The impact of lung cancer screening in Japan

Screening for lung cancer with low-dose spiral CT scan of the chest and sputum cytology

A breath test for lung cancer?

The bronchoscope in historical perspective

Lack of screening

Benefits of screening

Other methods of screening

Selected abstracts from Poster Sessions

Publication citation

ILCI Editorial Board

Smoking cessation guidelines now available

Differences in lung cancer between men and women

Imaging techniques utilized in the diagnosis and staging of lung cancer

Accurate diagnosis and staging critical to non-small-cell lung cancer patient management

Decision logic and the treatment of asymptomatic lung cancer recurrence

Patient outcomes and radical radiotherapy for stage 1 non-small-cell carcinoma

Lung volume reduction surgery for patients with severe dyspnea associated with advanced diffuse emphysema

Preoperative examination of lung transplant candidates

Diagnostic imaging key to early detection of lung cancer

Dr. Geno Saccomanno's pioneering studies in the cytologic diagnosis of lung cancer

Mortality statistics suggest need for new approach to diagnosis and treatment

Who gets lung cancer

Studies show powerful association of COPD and lung cancer

Study indicates smoking cessation reduces decline in FEV1

Lung cancer screening could improve survival